ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (2196 HK)

165
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
30 Sep 2024 00:35

Merger Arb Mondays (30 Sep) - Canvest, Henlius, CPMC, Xingda, Fuji Soft, Capitol, Dyna-Mac

This week, the highest gross spreads are Canvest (9.1%), GA Pack (8.6%), Henlius (8.1%), Shinko Electric (7.3%), China TCM (6.7%), Malaysia...

Logo
285 Views
Share
29 Sep 2024 16:02

China Healthcare Weekly (Sep29)- Henlius Privatization Update, NHSA Fee Control, Hansoh Is Exception

The approval process of Henlius' privatization is slow, but the deal will get up. Medical insurance fee control policies will continue. Different...

Logo
351 Views
Share
29 Sep 2024 07:00

Last Week in Event SPACE: DFI/JD.com/Yonghui, Alibaba/Sun Art, New World Development, Austal

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
361 Views
Share
bullishFuji Soft Inc
28 Sep 2024 15:00

(Mostly) Asia-Pac M&A: Dyna Mac, Platinum Asset, Fuji Soft, JTower, Arvida, Korea Zinc, Sun Art

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
399 Views
Share
23 Sep 2024 00:18

Merger Arb Mondays (23 Sep) - Henlius, GA Pack, China TCM, Canvest, Trancom, Fuji Soft, Platinum

This week, the highest gross spreads are Canvest (8.6%), Shinko Electric (7.2%), GA Pack (6.9%), Henlius (6.7%), China TCM (5.7%), Capitol Health...

Logo
366 Views
Share
x